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taining 300–3,000 mL of water), one
thermal bottle (250 mL), one plastic
bottle (50 mL), and one bucket (2,500
mL). Larvae were placed in plastic
bags and transported to CIP laborato-
ries, where they were allowed to
emerge to adults during 17 days. The
fourth instar larval and pupal exuvias
were fixed and identified to species
according to Darsie (7) and
Superintendência de Campanhas de
Saúde Pública (8). Twenty-five
female and male Ae. albopictus from
these collections are available from
CIP laboratory upon request. 
Additional field collections are
being conducted to establish the dis-
tribution range of this species along
the Chiapas coastal plain, to determi-
nate the entomologic levels of infesta-
tion, and to determine its susceptibili-
ty to insecticides. Considering the epi-
demiologic relevance of this discov-
ery, we have notified the proper health
authorities to take necessary control
measures to reduce the possibility of
increased dengue transmission and to
prevent other arboviruses, such as
West Nile virus (9), from being spread
by this new species in southern
Mexico. 
Mauricio Casas-Martínez* 
and José Luis Torres-Estrada*
*Centro de Investigación de Paludismo/
Instituto Nacional de Salud Pública,
Chiapas, México
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Virus Isolation and
“Acute” West Nile
Virus Encephalitis
(Response to
Huang et al.)
To the Editor: We read with inter-
est a recent article in your journal,
First Isolation of West Nile virus from
a Patient with Encephalitis in the
United States (1); in the report, we
were unable to ascertain indisputable
evidence that this patient had indeed
acquired acute West Nile virus
(WNV) encephalitis. In animals (2,3)
and humans (4), West Nile virus can
persist in the host even after the host
has recovered from an acute WNV
infection, presumably more so in the
immunocompromised persons. There-
fore, in the case described by Huang
et al. (1), proving that the patient did
not have a history of WNV infection
is important, particularly because this
patient is from a geographic area
where WNV is known to exist. The
findings at autopsy of perivascular
lymphocyte cuffing in mammillary
bodies of the brain are not the classic
findings reported during the West Nile
encephalitis outbreak in New York
City (5). The immunoglobulin (Ig) G
antibody against WNV, if it had been
present, would have been useful in
that IgG antibody in the absence of
IgM antibody is indicative of past
rather than acute infection.
The WNV copy numbers in clini-
cal samples and clinical indices
(leukocyte count) suggest that the
virus multiplies in the setting of
leukopoenia or immune suppression
and cannot be definitive proof that it
was an acute infection, unless a nega-
tive preillness sample was available.
The cause of the transient viremia,
whether acutely acquired or from
increased proliferation in a chronic
infection, needs to be clarified fur-
ther. In the future, antigen detection
will guide patient management deci-
sions; therefore, the possibility of a
human chronic carrier state warrants
study. 
Vijay K. Krishnamoorthy,* 
Jayashri Bhaskar,*
and John N. Sheagren*
*Advocate Illinois Masonic Medical Center,
Chicago, Illinois, USA
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“Acute” West Nile
Virus Encephalitis
(Response to
Krishnamoorthy 
et al.)
To the Editor: In a letter to the
editor, Krishnamoorthy et al. question
the diagnosis of “acute West Nile
encephalitis” in our case report. We
did not use the word “acute” in the
paper, but the patient did in fact have
an acute illness. We believe that this
case report, in which West Nile virus
(WNV) was isolated in cell culture,
represents the best evidence for a
WNV infection in a human in the
United States. The diagnosis of West
Nile encephalitis was based on clini-
cal analysis (1); not everyone with the
diagnosis undergoes an autopsy. In
many instances, patients do recover.
In our case, the patient had the clinical
features of encephalitis consisting of
unremitting fever associated with a
rapid course of progressive confusion
and lethargy followed by coma. In
addition, increased depression of res-
piratory drive existed, pointing to
brain stem involvement. We agree that
the inflammatory changes in the brain
were limited as compared to such
changes in other reported cases of
WNV; however, this limitation was
attributable to the fact that the patient
was both immunocompromised and
neutropenic at the time of acute infec-
tion. Therefore, the usual inflammato-
ry response cannot be expected. Even
though the changes were limited, they
were consistent with the histologic
findings in previously published
reports (1,2).
The second point by Krishna-
moorthy et al. represents their hypoth-
esis about a human chronic carrier
state for WNV. Although a chronic
carrier state is possible, the viremic
period associated with arboviral
infections is typically short (3). While
one cannot rule out persistent infec-
tion with WNV, until our report
attempts to recover the virus by isola-
tion in North America in humans have
been uniformly unsuccessful. Also,
previous reports of successful WNV
isolations by Israeli investigators in
immunocompetent hosts (4) have
been from blood specimens before
seroconversion. These considerations
indicate that the virus is not routinely
found in the blood in substantial
amounts by the time clinical symp-
toms consistent with WNV infection
occur. We do not know, nor have we
speculated, about the timing of the
infection as the patient had no recol-
lection of a mosquito bite. Tests for
both immunoglobulin (Ig) G and IgM
antibodies to WNV were negative in
our patient. Because the patient was
immunocompromised, a humoral
response was not expected; therefore,
this information cannot be used as
